Revolutionary study proves CBD inhibits hepatitis C virus
In 2017, it is estimated that at least 20 000 Americans will die from liver cancer, most of which is derived from HCV. New research on CBD and its effect on hepatitis convinced that cannabis would inhibit the hepatitis virus.
Important antiviral properties
A new study has revealed that CBD, one of the main cannabis compounds, has important antiviral properties, especially when it comes to protecting the body from the hepatitis C virus.
The study, conducted by Dr. Lowe, a professor at the University of Maryland School of Medicine, which was published in the highly respected Pharmacognosy Research Journal. So she suggests that CBD could be an effective treatment for more than 3 million Americans with HCV.
In 2017, it is estimated that at least 20 000 Americans will die from liver cancer, most of which is derived from HCV. The researchers who conducted the study found that the phytochemical, CBD, inhibits HCV, and is generally antiviral.
Traditionally, for the study of CBD, its anti-inflammatory, neuroprotective and antioxidant properties are those focused on research. This groundbreaking study looked much more closely at the CBD. Notably as an antiviral agent, and the results were convincing.
Dr. Lowe and his colleagues combined CBD and HCV under laboratory conditions. This finding that the isolated CBD inhibited HCV replication of 86,4% with a single application. As such, the study concluded that the direct antiviral effects of CBD could be effective against viral and non-veterinary hepatitis, also known as autoimmune hepatitis.
Effective on CB2 receivers
Although the researchers did not observe any antiviral effect of CBD on the hepatitis B virus (HBV) in vitro. They indicated that, based on various other clinical research, CBD could be antiviral against HBV in vivo. In particular, by the regulation of CB2 receptors in the body, positive immune responses for HCV and HBV have been observed.
Although there is already a cure in the hepatitis C market, it costs more than 100 000 $ for 12 weeks ... This treatment is effective and few side effects have been reported. The main problem is that many people can not afford such a heavy price.
Much more research is needed to examine the antiviral properties of CBD. However, this new study is a good foundation for new research. This is to introduce natural, holistic, and inexpensive natural remedies for viruses such as hepatitis.